DNA.WS
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
DNA.WS
Delisted
DNA.WS was delisted on the 3rd of September, 2024.
5 hedge funds and large institutions have $3.91K invested in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Holders
5
Holding in Top 10
–
Calls
$11K
Puts
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 | -$75.1K | |
| 2 | -$66.7K | |
| 3 | -$46.4K | |
| 4 |
JRCM
Jones Road Capital Management
New York
|
-$16.7K |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$11.3K |